Description:

ALKS is the ticker symbol for Alkermes plc (ALKS), a biopharmaceutical company that focuses on developing and commercializing innovative medicines to improve patient outcomes in central nervous system (CNS) disorders. Listed on the New York Stock Exchange, Alkermes has been a significant player in the healthcare sector, particularly in the areas of addiction, schizophrenia, and depression. The company's research and development efforts are geared towards advancing treatments that address unmet medical needs, aiming to enhance the quality of life for patients suffering from these complex conditions.

Data:

Yields: